title: Mirtazapine treatment of diabetic gastroparesis as a novel method to reduce tube-feed residual: a case report.
abstract: BACKGROUND
  Gastroparesis is a common motility disorder that is characterized by delayed gastric emptying in the absence of mechanical obstruction. Diabetes, along with other neuromuscular and infiltrating disorders, can predispose individuals to an increased risk of developing gastroparesis. Gastroparesis can be easily diagnosed through gastric emptying studies but is usually difficult to successfully treat. Therapy usually begins with pro-kinetic and anti-emetic agents.
  
  
  METHODS
  Our patient was an 87-year-old African-American woman who was a nursing home resident, with a history of diabetes mellitus type 2 and subarachnoid hemorrhage leading to aphasia, hemiplegia, seizures and dysphagia requiring percutaneous gastric feeds. While at the nursing home, she had recurrent aspiration pneumonia and large tube-feed residuals consistent with a diagnosis of underlying gastroparesis. Her management included metoclopramide and reduced tube-feeding rates, which improved her symptoms. However, within months the aspiration and increased residuals returned. After trials of different medication therapies without success, she started mirtazapine and her residual volume and aspirations decreased with a dose of 15mg nightly.
  
  
  CONCLUSIONS
  In patients with gastroparesis recalcitrant to first line therapies such as metoclopramide, off-label use of mirtazapine may provide adequate non-invasive management of gastroparetic symptoms.
authors: Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. gooden.janelle@mayo.edu.
authors: Janelle Y
authors: JY
authors: Gooden
authors: Paul Y
authors: PY
authors: Takahashi
references: Surgery. 2008 Oct;144(4):566-72; discussion 572-4
references: 18847640
references: Best Pract Res Clin Gastroenterol. 2007;21(4):645-55
references: 17643906
references: Neurogastroenterol Motil. 2010 Feb;22(2):113-33
references: 20003077
references: BMJ Case Rep. 2009;2009:
references: 21847421
references: Rev Med Liege. 2005 May-Jun;60(5-6):509-15
references: 16035319
references: Psychosomatics. 2006 Sep-Oct;47(5):440-2
references: 16959934
references: Am J Gastroenterol. 2008 Aug;103(8):2023-30
references: 18796098
references: Eur J Gastroenterol Hepatol. 2008 Sep;20(9):822-5
references: 18794593
references: Gastroenterology. 1987 Jan;92(1):40-7
references: 3023168
references: World J Gastroenterol. 2009 Jan 7;15(1):25-37
references: 19115465
references: Gastroenterol Hepatol (N Y). 2010 Jun;6(6):1-16
references: 20733935
references: Diabetologia. 1990 Nov;33(11):675-80
references: 2076799
references: Am Fam Physician. 1999 Jan 1;59(1):159-61
references: 9917581